| Website | integenx.com |
| Category | BioTech |
| Phone | (925) 701-3400 |
| Employees |
| GenVault, 2/11 |
| TOTAL | $55.6M |
| VENTURE FUNDING TOTAL | $55.6M |
| Series B, 2/11 Domain Associates In-Q-Tel RONAholdings | $15.6M |
| Series C, 12/11 Domain Associates QuestMark Partners Greenspring Associates Cross Creek Capital RONAholdings Samsung Ventures In-Q-Tel | $40M |
IntegenX, Inc. designs, manufactures, and markets automation systems that enable reliable microsample preparation and analysis for the life sciences. It offers Apollo 100, a platform that allows the processing of DNA sequencing reactions; Apollo 200, an integrated sample preparation system for human DNA identification; microfluidics for DNA sequencing, molecular diagnostics, and human identification applications; and Apollo 324 system, a benchtop robotic workstation that automates the construction of DNA fragment libraries for next-generation sequencing. The company was formerly known as Microchip Biotechnologies, Inc. and changed its name to IntegenX, Inc. in March 2010. The company was incorporated in 2003 and is based in Pleasanton, California.
